Cavan John T 4
4 · Hepion Pharmaceuticals, Inc. · Filed Apr 7, 2020
Insider Transaction Report
Form 4
Cavan John T
Chief Financial Officer
Transactions
- Award
Stock Options
2020-04-03+215,000→ 221,059 totalExercise: $1.63Exp: 2030-04-03→ Common Stock (215,000 underlying)
Footnotes (1)
- [F1]71,667 of the stock options vest on 4/3/2021 and the remainder vests monthly in equal amounts over 24 months.